ID
17536
Description
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.; ODM derived from: https://clinicaltrials.gov/show/NCT00087594
Link
https://clinicaltrials.gov/show/NCT00087594
Keywords
Versions (1)
- 9/22/16 9/22/16 -
Uploaded on
September 22, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatitis C, Chronic NCT00087594
Eligibility Hepatitis C, Chronic NCT00087594
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Prior Therapy Hepatitis C, Chronic
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0524910
Description
HIV coinfection
Data type
boolean
Alias
- UMLS CUI [1]
- C4062778
Description
Illicit drug use Intravenous | Illicit drug use
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0281875
- UMLS CUI [1,2]
- C1522726
- UMLS CUI [2]
- C0281875
Description
Decompensated cirrhosis
Data type
boolean
Alias
- UMLS CUI [1]
- C1619727
Description
Pregnancy | Breast Feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Similar models
Eligibility Hepatitis C, Chronic NCT00087594
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C1148363 (UMLS CUI [2])
C0524910 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2])
C0524910 (UMLS CUI [1,2])
C1522726 (UMLS CUI [1,2])
C0281875 (UMLS CUI [2])
C0006147 (UMLS CUI [2])